Inflammatory activity and vitamin D levels in an MS population treated with rituximab.

Linden, Johan; Granåsen, Gabriel; Salzer, Jonatan; Svenningsson, Anders; Sundström, Peter

Linden, Johan; Granåsen, Gabriel; Salzer, Jonatan; Svenningsson, Anders; Sundström, Peter.

Afiliação

Linden J; Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden.
Granåsen G; Department of Public Health and Clinical Medicine, Umeå University, Sweden.
Salzer J; Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden.
Svenningsson A; Department of Clinical Sciences, Danderyd Hospital, Sweden.
Sundström P; Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden.

Mult Scler J Exp Transl Clin ; 5(1): 2055217319826598, 2019.

Article em En | MEDLINE | ID: mdl-30800416

Palavras-chave

MRI; Multiple sclerosis; disease-modifying therapies; rituximab; vitamin D

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mult Scler J Exp Transl Clin Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google